Working… Menu

Nebulized Fentanyl in Patients With Mild to Moderate Interstitial Lung Disease and Chronic Dyspnea

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03018756
Recruitment Status : Suspended (Temporarily suspended due to COVID-19)
First Posted : January 12, 2017
Last Update Posted : January 20, 2021
Boehringer Ingelheim
Information provided by (Responsible Party):
Dr. Denis O'Donnell, Queen's University

No Study Results Posted on for this Study
Recruitment Status : Suspended
Actual Primary Completion Date : June 25, 2018
Estimated Study Completion Date : August 1, 2022